Optinose 表示,该试验共招募了 332 名患者,与安慰剂相比,该试验同时满足了两个共同主要终点。第一个是...查看全文
产业链观察2022-03-07 20:50
药闻▶2022 年 3 月 7 日— 专注于耳鼻喉 (ENT) 和过敏专家治疗的患者的制药公司$OptiNose(OPTN)$ ,今天宣布 ReOpen1 临床试验满足了其共同主要终点。
在接受 XHANCE®(丙酸氟替卡松)呼气输送系统™治疗的慢性鼻窦炎患者中显示出统计学上的显着改善在 ReOpen1 临...查看全文
破落鸭头2020-11-02 13:05
$OptiNose(OPTN)$ 这个公司的产品简单粗暴,有点搞笑。但鼻窦炎似乎是个很大的市场,拳头产品Xhance销量迅速增长,最近筹了4000万@5.85,专业投资人站在了山岗上
我觉得小散们可以上查看全文
$OptiNose(OPTN)$ DEF 14A - Other definitive proxy statements Filed: 2019-04-24 AccNo: 0001494650-19-000037 Size: 1 MB 网页链接
$OptiNose(OPTN)$ CT ORDER - Confidential treatment order Filed: 2019-03-20 AccNo: 9999999997-19-001662 Size: 91 KB 网页链接
$OptiNose(OPTN)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-03-14 AccNo: 0001144204-19-013785 Size: 88 KB 网页链接
$OptiNose(OPTN)$ 8-K - Current report Filed: 2019-03-06 AccNo: 0001494650-19-000018 Size: 2 MBItem 2.02: Results of Operations and Financial ConditionItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$OptiNose(OPTN)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-03-06 AccNo: 0001494650-19-000020 Size: 7 MB 网页链接
$OptiNose(OPTN)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2019-03-06 AccNo: 0001494650-19-000021 Size: 93 KB 网页链接
$OptiNose(OPTN)$ 美东时间 2019-03-06 盘前 披露财报,预期EPS -0.84 网页链接
$OptiNose(OPTN)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-13 AccNo: 0000315066-19-001253 Size: 8 KB 网页链接
$OptiNose(OPTN)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-07 AccNo: 0001193125-19-030993 Size: 98 KB 网页链接
$OptiNose(OPTN)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-06 AccNo: 0001494650-19-000014 Size: 150 KB 网页链接